These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21986835)

  • 21. Cefepime induced acute interstitial nephritis--a case report.
    Mac K; Chavada R; Paull S; Howlin K; Wong J
    BMC Nephrol; 2015 Feb; 16():15. PubMed ID: 25886295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute renal failure in the critically ill patient.
    Abernethy VE; Lieberthal W
    Crit Care Clin; 2002 Apr; 18(2):203-22, v. PubMed ID: 12053831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit.
    Alagha Z; Crow S; Abdeen AMZ; Alastal M; Alastal A
    J Investig Med High Impact Case Rep; 2024; 12():23247096241259534. PubMed ID: 39068595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
    Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
    J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of bilateral bispectral index (BIS) monitoring in a comatose patient with myoclonic status epilepticus secondary to cefepime.
    Fernández-Torre JL; Hernández-Hernández MA; Rodríguez-Borregán JC; González-Quintanilla V
    Epileptic Disord; 2013 Dec; 15(4):444-50. PubMed ID: 24169368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefepime: a novel cause of thrombocytopaenia.
    Muhammad S; Ahmad S; Khan BA; Yousaf A
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red man syndrome adverse reaction following intravenous infusion of cefepime.
    Panos G; Watson DC; Sargianou M; Kampiotis D; Chra P
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6387-8. PubMed ID: 22948884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
    Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
    Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefepime-related encephalopathy in peritoneal dialysis patients.
    Lin CJ; Chen SP; Wang SJ; Fuh JL
    J Chin Med Assoc; 2011 Feb; 74(2):87-90. PubMed ID: 21354086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.
    Ferreira JA; Johnson DW
    Ren Fail; 2015 Aug; 37(7):1232-6. PubMed ID: 26108135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
    Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombocytopenia and outcome in critically ill patients with bloodstream infection.
    Vandijck DM; Blot SI; De Waele JJ; Hoste EA; Vandewoude KH; Decruyenaere JM
    Heart Lung; 2010; 39(1):21-6. PubMed ID: 20109983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease.
    Nguyen DD; Lai S
    Am J Case Rep; 2022 Jan; 23():e934083. PubMed ID: 35067669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefepime Pharmacokinetics in Critically Ill Pediatric Patients Receiving Continuous Renal Replacement Therapy.
    Stitt G; Morris J; Schmees L; Angelo J; Akcan Arikan A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric cefepime neurotoxicity.
    Landgrave LC; Lock JL; Whitmore JM; Belcher CE
    Pediatr Neurol; 2012 Dec; 47(6):458-60. PubMed ID: 23127270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.